BRIEF — Bexorg Awarded Up To $28.3 Million From Arpa — H To Advance Human Brain Translational Pharmacology For Cns Drug Development
Oct 7 (Reuters) — Bexorg Awarded Up To $28.3 Million From Arpa-h To Advance Human Brain Translational Pharmacology For Cns Drug Development Bexorg: Arpa-h Project To Extend Brainex Perfusion From 24 Hours To Up To Two Weeks For Longitudinal Studies Source text:... (Reuters.Briefs@thomsonreuters.com;)